Screening and Evaluation In Vitro of Bacillus-Based Probiotics for Feed Additives

In the post-antibiotic era, the Bacillus-based direct-fed beneficial microorganisms are emerging as a cornerstone for sustainable animal farming. This study aimed to screen and evaluate Bacillus strains with probiotic potential for use as feed additives. A total of 394 Bacillus strains were initially screened based on their extracellular enzyme production (cellulase, protease, and amylase) and antibacterial activities against Escherichia coli, Staphylococcus aureus, and Salmonella enterica. Two strains, Bacillus velezensis FJAT-10508 and FJAT-13563, were selected and subsequently subjected to in vitro probiotic characterization, safety assessment, and whole-genome analysis. The results demonstrated that both strains exhibited α-hemolysis, acceptable antibiotic susceptibility profiles, absence of invasion and cytotoxicity effect on the Caco-2 cells, and no mobile virulence or antibiotic resistance genes, indicating their safety as probiotic candidates. High endospore-forming efficiencies (72.4-90.8%), strong auto-aggregation (74-85%) and co-aggregation abilities (52-82%) were observed. In addition, both strains showed considerable tolerance to simulated gastrointestinal conditions, with vegetative cell and endospore survival rates of 28.33-38.33% and 85-89.67% at pH 2.0, and 38.33-43.33% and 90.33-96.33% in 0.3% bile salts, respectively. Overall, B. velezensis FJAT-10508 and FJAT-13563 demonstrated robust in vitro probiotic properties, supporting their potential application as reliable Bacillus-based feed additives.